Louisiana's climate fosters a variety of allergens, like pollen and mold. And as an "allergy capital," the city rarely gets ...

The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric ...

Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm ...

As pet owners, we always want the best for our furry companions. While we often focus on their health, diet, and daily ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

The FDA has proposed ending the use of a common ingredient found in many cold and allergy medicines — and some pharmacies ...

Allergens like mold, pollen, and dust, if you’re sensitive to them, can inflame the throat and affect mucus production.

We tend to think of COVID-19 as a respiratory illness. But, like many viruses, COVID can also affect your skin and cause ...

No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more ...

Are you one of these people who loathes spending time outdoors at dusk as the weather warms and mosquitoes start biting?